MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,821K
EPS
-$2.44
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
3,343
4,093
12,709*
4,307
General and administrative
6,873
4,787
6,573*
4,348
Impairment of long-lived assets
-
-
1,536*
-
Net gain on lease terminations
1,944
633
-
-
Loss from operations
-8,272
-8,247
-20,818*
-8,655
Other income (expense), net
451
688
992*
906
Net loss
-7,821
-7,559
-19,827*
-7,749
Unrealized gain (loss) on marketable securities
-
-
-2*
-
Comprehensive loss
-7,821
-7,559
-19,829
-7,749
Basic EPS
-2.44
-2.36
-6.253
-2.44
Diluted EPS
-2.44
-2.36
-6.253
-2.44
Basic Average Shares
3,208,744
3,205,866
3,170,967
3,178,710
Diluted Average Shares
3,208,744
3,205,866
3,170,967
3,178,710
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$7,821K
(16.66%↑ Y/Y)
Net loss
-$7,821K
(16.66%↑ Y/Y)
Other income
(expense), net
$451K
(-52.48%↓ Y/Y)
Loss from operations
-$8,272K
(19.95%↑ Y/Y)
General and
administrative
$6,873K
(52.06%↑ Y/Y)
Research and development
$3,343K
(-42.50%↓ Y/Y)
Buy us a coffee
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)